Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera E Valkhoff

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Gastroenterology|May 1, 2012
Risk factors for gastrointestinal bleeding associated with low-dose aspirinVera E Valkhoff, Miriam C J M Sturkenboom, Ernst J Kuipers
Gastroenterology|September 28, 2013
Reply: To PMID 23470618I Lisanne Holster, Vera E Valkhoff, Eric T T L Tjwa
Gastroenterology|March 9, 2013
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysisI Lisanne Holster, Vera E Valkhoff, Ernst J Kuipers, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2011
[Clopidogrel and proton pump inhibitors: insufficient evidence of interaction]Nicole G M Hunfeld, Vera E Valkhoff, Daan J Touw, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 22, 2013
Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studiesVera E Valkhoff, Miriam C J M Sturkenboom, Catherine Hill, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagusFlorine Kastelein, Manon C W Spaander, Ewout W Steyerberg, et al.
British Journal of Clinical Pharmacology|March 18, 2015
Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort studyMargaretha F Warlé-van Herwaarden, Aafke R Koffeman, Vera E Valkhoff, et al.
American Journal of Physiology. Cell Physiology|December 31, 2010
NHERF1 and NHERF2 are necessary for multiple but usually separate aspects of basal and acute regulation of NHE3 activityRafiquel Sarker, Vera E Valkhoff, Nicholas C Zachos, et al.
Arthritis and Rheumatism|April 18, 2012
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based studyVera E Valkhoff, Eva M van Soest, Giampiero Mazzaglia, et al.
Expert Opinion on Drug Safety|December 6, 2013
Development and application of indicators for the reduction of potentially preventable hospital admissions related to medicationsMargaretha F Warlé-van Herwaarden, Vera E Valkhoff, Martina Teichert, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Gastroenterology|May 1, 2012
Risk factors for gastrointestinal bleeding associated with low-dose aspirinVera E Valkhoff, Miriam C J M Sturkenboom, Ernst J Kuipers
Gastroenterology|September 28, 2013
Reply: To PMID 23470618I Lisanne Holster, Vera E Valkhoff, Eric T T L Tjwa
Gastroenterology|March 9, 2013
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysisI Lisanne Holster, Vera E Valkhoff, Ernst J Kuipers, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2011
[Clopidogrel and proton pump inhibitors: insufficient evidence of interaction]Nicole G M Hunfeld, Vera E Valkhoff, Daan J Touw, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 22, 2013
Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studiesVera E Valkhoff, Miriam C J M Sturkenboom, Catherine Hill, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagusFlorine Kastelein, Manon C W Spaander, Ewout W Steyerberg, et al.
British Journal of Clinical Pharmacology|March 18, 2015
Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort studyMargaretha F Warlé-van Herwaarden, Aafke R Koffeman, Vera E Valkhoff, et al.
American Journal of Physiology. Cell Physiology|December 31, 2010
NHERF1 and NHERF2 are necessary for multiple but usually separate aspects of basal and acute regulation of NHE3 activityRafiquel Sarker, Vera E Valkhoff, Nicholas C Zachos, et al.
Arthritis and Rheumatism|April 18, 2012
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based studyVera E Valkhoff, Eva M van Soest, Giampiero Mazzaglia, et al.
Expert Opinion on Drug Safety|December 6, 2013
Development and application of indicators for the reduction of potentially preventable hospital admissions related to medicationsMargaretha F Warlé-van Herwaarden, Vera E Valkhoff, Martina Teichert, et al.
Pageof 3